ADSL and infection: However, a major challenge in using AMPs for internal infections is that they are often readily degraded in the body and thus cannot reach the site of infection in sufficient quantities when orally administered.14, 15 To overcome this delivery challenge, we are engineering probiotic bacteria that can survive passage through and temporarily reside in the GI tract.